Drug Discovery Chemistry
WuXi AppTec is proud to have 3 speakers at this year’s Drug Discovery Chemistry (DDC) meeting, showcasing the latest advances in fragment-based drug discovery, DNA-encoded library technology, and screening approaches to identify RNA-binding molecules. As a global leader in providing state-of-the-art services to support small molecule-based drug discovery, WuXi AppTec offers a comprehensive platform of screening techniques, biophysical assays, and customized chemical syntheses.
Our scientists welcome the opportunity to meet with you at DDC 2023! Visit us at booth 417 to get your screening-related questions answered by our experts. For a dedicated meeting time, you can also pre-arrange a one-on-one discussion by completing this brief form, or contacting us at discoveryservices@wuxiapptec.com
WuXi AppTec Speaker Presentations
| Track | Date | Speaker | Title of Talk |
| RNA Targeting Small Molecule Drugs | Tuesday April 11, 9:55 -10:10 | Zhifeng Yu | Discovery of RNA Targeting Small Molecules: Our Toolbox for RNA Drug Discovery |
| Fragment Based Drug Discovery | Wednesday April 12, 12:00-12:15 | Moran Jerabek-Willemsen | Biophysical and Structural Biology Methods Enable Fragment-based Covalent Ligand Discovery of Human BTK |
| Encoded Libraries for Drug Discovery | Thursday April 13, 12:50-1:20 | Alex Satz | DNA-Encoded Libraries for the Discovery of Small-Molecule Hits |
Download Our Literature on DEL, Fragment Screening, Proteolysis Targeting Chimera (PROTAC) drugs, and RNA Targeting here:
- Targeted Protein Degradation
- DNA-Encoded Library Screening: DELpro
- Fragment Screening and DEL: Target-to-Hit
- Open Access DEL Platform
- DELight Handbook
- White Paper: Bifunctional Molecules
- White Paper: DEL and FBDD Biophysical Methods
- Discovery of RNA Targeting Small Molecules Using DEL
- Publication: Discovery of SARS-CoV-2 main protease covalent inhibitors using DEL
